No current openings posted at Aclid.
Startups often hire before a role is posted. If Aclid's work sounds like a fit, reach out with a general application through their website.
Send a general application ↗
Aclid describes itself as the leading automation platform for biosecurity and biosafety. It offers an end-to-end platform for real-time screening, research verification, and compliance management.
The company's platform provides real-time threat assessments for genes, libraries, and plasmids, and automates verification of licenses and biosafety guidelines. It also includes sanctions and watchlist screening for customers.
Aclid serves companies in the biotech and synthetic biology sectors that need to manage biosecurity, biosafety, and biodefense compliance. The company says it is trusted by industry leaders.
Aclid states it is on a mission to secure the bioeconomy. The company was founded in 2021 by pioneers in biosecurity and synthetic biology, aiming to make genetic engineering safer and more accessible.
The company says it started because safety and security were growing more complicated amid record-breaking growth of synthetic biology, and it recognized the difficulty for biotech startups to build a strong foundation.
Written from what Aclid publishes on its own website: aclid.bio, aclid.bio/about, aclid.bio/product/sanctions-and-watchlists (read November 11, 2026).
No current openings posted at Aclid.
Startups often hire before a role is posted. If Aclid's work sounds like a fit, reach out with a general application through their website.
Send a general application ↗